Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Convalescent plasma Emergency use authorization Experimental Antiviral Mar/30/2021 34 6
Remdesivir Approved by FDA Experimental Antiviral Mar/23/2021 60 4
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Mar/19/2021 81 18
Anakinra  Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/08/2021 15 2
Epigallocatechin Gallate Potential treatment - pre-clinical evidence Natural product Antiviral Feb/24/2021 10 0
FN3B Potential treatment - pre-clinical evidence Experimental Antiviral Feb/05/2021 1 0
FN3C Potential treatment - pre-clinical evidence Experimental Antiviral Feb/05/2021 1 0
FN3D Potential treatment - pre-clinical evidence Experimental Antiviral Feb/05/2021 1 0
FN3A Potential treatment - pre-clinical evidence Experimental Antiviral Feb/05/2021 1 0
ELI-005 Potential treatment - pre-clinical evidence Experimental Vaccine Feb/05/2021 1 0